Implementation of the 15th Five-Year Plan: Five Major Policy Themes and 286 Beneficiary Stocks

Overview

This report is J.P. Morgan's in-depth follow-up analysis of China's 15th Five-Year Plan (2026-2030). The report argues that as the plan has been in the public domain for months, the core investment question has shifted from 'what are the policy directions' to 'which areas are truly executable and tradable'. Through a structured NLP framework to quantitatively analyze the 2026 Government Work Report, the report identifies that policy intensity is concentrating from broad signals to a few high-priority clusters, and accordingly constructs a 'policy-supported' investment portfolio of 286 stocks. This portfolio significantly outperforms non-supported stocks in fundamentals and growth potential, with core opportunities concentrated in five themes: artificial intelligence, energy security, advanced manufacturing, unified national market and anti-involution, and medical innovation.

Core views

Macro paradigm shift: security over efficiency. The report notes that the 15th Five-Year Plan formally establishes a shift in the global economic organization model that has gradually formed since the China-US trade war, moving from 'efficiency-first globalization' to 'security-first economic organization'. China's response strategy clearly points to self-sufficiency in core technologies, enhanced supply chain resilience, expanded strategic buffers in food and energy, and maintaining industrial capacity operations amid external uncertainties. 'High-quality development' remains the goal, but the means to achieve it focus more on solving bottlenecks in a fragmented world and translating strategic intent into on-the-ground execution. The plan text no longer mentions 'peace and development as the themes of the times', instead emphasizing a external environment of frequent geopolitical conflicts, rising unilateralism, and intensifying great power competition. Five policy clusters and investment opportunities. NLP analysis reveals that 2026 policy deployment shows high concentration, with five thematic clusters offering the most investment value: 1. Artificial Intelligence (AI): evolving into a national-level infrastructure cycle. Policy support covers the full stack, from semiconductors, optical networks, storage to computing infrastructure, extending to cloud deployment and vertical applications. AI hardware is the clearest near-term earnings and growth visibility. Market consensus expects MSCI China A-share IT sector 2026 EPS growth of ~132%, reflecting accelerated expectations of capacity building translating into revenue. The investment logic lies in the 'infrastructure to application' flywheel effect, with opportunities concentrated in upstream materials, components, and equipment. 2. Energy Security: structural capex theme. Grid modernization, energy storage, smart power systems, and transmission infrastructure are at the core of China's resilience agenda. Grid capex during the 15th Five-Year Plan may exceed RMB 5 trillion, with UHV annual investment over RMB 100 billion. Policy direction benefits 'pick-and-shovel' segments like transmission and distribution equipment, grid automation, power electronics, and the energy storage value chain. 3. Advanced Manufacturing: hub of productivity upgrade. Policies continue to support automation, industrial software, high-end equipment, and import substitution. The 2026 Government Work Report explicitly allocates RMB 200 billion in ultra-long-term special bonds for large-scale equipment renewal. High-tech industry value-added grew 12.5% y-y in March 2026, leading industrial sectors. Investment logic anchors on multi-year capex, innovation, and localization cycles, benefiting import substitution and productivity tool companies. 4. Unified National Market and Anti-Involution: improving profitability. Policies aim to break local protectionism and market fragmentation, correcting price wars and inefficient redundant construction. This will shift industries from 'fragmented growth + margin compression' to 'national scale + rational competition', benefiting leading companies in logistics, chain formats, consumer brands, and building materials in gaining market share and pricing power. 5. Medical Innovation: 'Healthy China' as a growth pillar. Policies elevate healthcare from a social agenda to a growth and resilience pillar, supporting full-chain development in innovative drugs, medical devices, and biomanufacturing. Central procurement and医保 payment mechanisms continue to optimize, supporting differentiated pipelines and CDMO/CRO demand; traditional Chinese medicine also receives inheritance, innovation, and industrialization support. Fundamental advantages of policy-supported stocks. Based on this framework, the report screens 286 liquid policy-supported stocks from MSCI China (offshore + onshore). Data shows this group has significantly stronger fundamentals: Bloomberg consensus expects 2025-2027 EPS CAGR of 43%, far exceeding non-supported stocks' 18%; 2025 ROE is 14.7%, higher than non-supported stocks' 12.8%. Although this group has a 2026E P/E premium, valuation appears reasonable from a PEG perspective, reflecting stronger structural tailwinds. Sector-wise, it is concentrated in healthcare, IT, utilities, industrials, and consumer discretionary.

Analysis framework

The report adopts a systematic methodology of 'NLP policy quantification → thematic mapping → stock screening → portfolio construction' to transform qualitative policy texts into tradable quantitative asset pools. First, a structured NLP framework is used to benchmark the 2026 Government Work Report. Analysis dimensions include: policy intensity (mention frequency, significance, and operational details), directionality (degree of addition or reinforcement compared to previous years), policy persistence (alignment with long-term goals like five-year plans). Each policy cluster is scored 1-5 for priority, identifying execution-oriented themes like AI, computing infrastructure, and advanced manufacturing with the highest scores. Second, policy themes are mapped to third-party thematic indices. Based on the indices' investment logic and underlying exposures, indices that best represent policy transmission mechanisms (e.g., capex cycles, infrastructure, standard setting, procurement reforms) are screened and categorized as 'direct beneficiaries' or 'indirect beneficiaries'. Direct beneficiaries are typically at bottleneck segments of policy execution (core suppliers, critical infrastructure), with higher order and earnings visibility; indirect beneficiaries are mostly downstream applications or ecosystem spillovers, with greater elasticity but stronger lag. Finally, investable stock baskets are constructed. Liquidity screening is conducted within MSCI China onshore and offshore constituents, retaining stocks mapped to direct beneficiary indices. To avoid overlap and ensure thematic breadth, hierarchical clustering groups by thematic label similarity, prioritizing large-cap, high-liquidity stocks within each sub-cluster, with weights determined by liquidity weighting. This process ensures the portfolio has both policy alignment and diversification/implementability.

Methodology notes

• Industry/Sector Analysis FrameworkS-Curve Adoption

  AI's evolution from tech theme to national infrastructure cycle

  The report positions AI as a national-level productivity project akin to traditional infrastructure, not a short-term tech trend. This means AI is transitioning from the early adoption phase to large-scale infrastructure deployment in the S-curve, with policy focus shifting from R&D to 'new infrastructure' like computing clusters and optical networks, and investment logic shifting from hype to hardware earnings realization and operating leverage.

• Industry/Sector Analysis FrameworkUpstream-Midstream-Downstream Transmission

  Direct vs. indirect beneficiary dichotomy

  The report clearly distinguishes positions in the policy transmission chain when screening stocks: direct beneficiaries are at bottleneck segments (e.g., AI chips, grid equipment), receiving policy funding and orders first with high earnings certainty; indirect beneficiaries are downstream applications or ecosystem配套 (e.g., AI software, NEVs), with longer, more volatile benefit paths. This layering helps investors choose 'pick-and-shovel' vs. 'gold rush' plays based on risk appetite.

• Company Fundamentals & Financial FrameworkPEG Valuation

  Using PEG to validate policy-supported stock valuations

  The report acknowledges policy-supported stocks' 2026E P/E premium but argues合理性 via PEG (PE to growth ratio). When a stock group's earnings growth (43% CAGR) far exceeds market average (18%), static P/E undervalues its growth potential; PEG more fairly reflects 'paying for growth'性价比, serving as a common valuation anchor for growth-themed investing.

• Event Gaming & Behavioral FinanceEvent-driven analysis

  NLP-quantified policy texts as forward-looking signals

  The report avoids subjective interpretation, instead using NLP to analyze government work reports' word frequency, semantics, and structure, transforming policy texts into quantifiable 'intensity scores'. This method assumes wording changes in official documents are leading indicators of resource allocation, with score jumps often corresponding to subsequent fiscal, credit, and regulatory resource倾斜, enabling early capture of policy红利 windows.

Key data

• Policy-supported stocks 2025-27 EPS CAGR43%Bloomberg consensus, significantly higher than non-supported stocks' 18%
• Policy-supported stocks 2025 ROE14.7%Higher than non-supported stocks' 12.8%, showing stronger profitability
• MSCI China A-share IT sector 2026E EPS growth~132%IBES consensus, reflecting accelerated AI capacity-to-revenue conversion
• 15th Five-Year Plan grid capex forecast>RMB 5 trillionJ.P. Morgan channel checks, with UHV annual investment >RMB 100 billion
• March 2026 high-tech industry value-added growth12.5% y-yLeading China's industrial sectors, reflecting advanced manufacturing policy effectiveness
• Large-scale equipment renewal special bondsRMB 200 billionExplicitly allocated in 2026 Government Work Report to support equipment upgrades
• Number of policy-supported stocks286After liquidity screening, constituting 42% of MSCI China (onshore+offshore) 676 constituents

Impact & implications

The report argues China's policy cycle has entered an 'execution-ready' phase, where investment opportunities are no longer evenly distributed across macro narratives but highly concentrated in a few structural clusters with policy intensity, earnings visibility, and implementation clarity. For investors, this means shifting from broad index allocation to precise thematic exposure, focusing on companies at policy transmission bottlenecks that can率先 convert fiscal and institutional resources into orders and profits. Meanwhile, 'anti-involution' and unified market reforms may reshape competition in multiple traditional industries, freeing leading companies from price wars for systemic profitability修复. Dual drivers of energy security and AI infrastructure will also bring cross-cycle capex红利 to power equipment, energy storage, and computing产业链.

Risks

• Advanced manufacturing faces uneven execution, commoditized segment competition, and geopolitical conflict risks
• AI theme has high valuation (2026E weighted PE of 70.2x), potential for correction if commercialization lags
• Medical innovation remains subject to central procurement and医保 payment adjustments, with uncertain commercialization paths
• Renewable energy absorption pressures during energy transition may constrain some project returns
• External uncertainties (trade barriers, tech封锁) may disrupt supply chain autonomy进程

What to watch

• Actual progress in AI infrastructure deployment and downstream application monetization
• Grid capex implementation, especially UHV and energy storage project tenders and deliveries
• RMB 200 billion equipment renewal bond fund disbursement and project application progress
• Unified market regulation legislation and enforcement cases, plus anti-involution policy落地 effects by sector
• Innovative drug approvals and医保谈判 dynamics, plus biomanufacturing tech breakthroughs and pilot projects